Table 7 Urine Osmolality for the Experimental group with daily PA, SRWC, and PRAL subgroup analyses (Mean (SE)).
From: Acid-base balance and hydration status following consumption of mineral-based alkaline bottled water
Experimental Condition | Pre-Treatment Period | Treatment Period | Post-Treatment Period | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | M11 | M12 | |
All Subjects | 373 | 367 | 387 | 375 | 343 | 396 | † 435 | † 440 | † 445 | 376 | 358 | 360 |
(n = 19) | (28) | (39) | (47) | (32) | (40) | (42) | (41) | (44) | (40) | (38) | (31) | (35) |
Low PA (n = 9) | 372 (45) | 390 (68) | 409 (73) | 403 (52) | 368 (79) | 379 (80) | 444 (87) | 451 (87) | 417 (82) | 426 (64) | 383 (49) | 420 (70) |
High PA (n = 10) | 374 (36) | 346 (45) | 368 (63) | 350 (41) | 330 (56) | 412 (51) | 427 (48) | 430 (50) | † 473 (45) | 330 (42) | 335 (40) | 340 (45) |
Low SRWC (n = 9) | 418 (39) | 477 (58) | 505 (79) | 467 (41) | 460 (43) | 504 (47) | † 574 (46) | † 581 (45) | † 562 (46) | 441 (59) | 414 (41) | 480 (70) |
High SRWC (n = 10) | 333 (37) | 268 (28) | 281 (28) | 292 (31) | 238 (36) | 299 (29) | 310 (42) | 315 (43) | 332 (45) | 318 (44) | 308 (41) | 354 (36) |
Low PRAL (n = 9) | 355 (44) | 342 (61) | 450 (65) | 343 (38) | 336 (40) | 362 (45) | 412 (49) | 419 (50) | 376 (50) | 345 (46) | 351 (49) | 413 (65) |
High PRAL (n = 10) | 390 (36) | 389 (51) | 331 (46) | 404 (51) | 349 (42) | 427 (44) | 456 (48) | † 460 (45) | † 470 (45) | 404 (61) | 365 (41) | 4141 (39) |